NCT01998672View on ClinicalTrials.gov

Multiple Ascending Oral Dose Phase I Study With Px-102

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy
Interventions
DRUG

Px-102

Px-102 drinking solution, 0.5 mg/kg, 1.0 mg/kg and 1.5 mg/kg

DRUG

Placebo

Drinking solution

Trial Locations (1)

Unknown

FOCUS Clinical Drug Development GmbH, Neuss

Sponsors
All Listed Sponsors
lead

Phenex Pharmaceuticals AG

INDUSTRY

NCT01998672 - Multiple Ascending Oral Dose Phase I Study With Px-102 | Biotech Hunter | Biotech Hunter